MapLight Therapeutics, Inc. — Form 4
Filed July 30, 2026 · analyzed by the Insider Agent
4
▲ Likely positive
significance 78/100
What the filing says
10% owner Catalyst4, Inc. (MLPT) bought 1.2M shares (~$15.3M) on the open market (5.5% of holdings). Open-market insider purchase — historically a bullish signal.
Why this rating
Open-market insider purchase — historically a bullish signal.
See more from July 30, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.